首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >UC 729-6 a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas.
【2h】

UC 729-6 a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas.

机译:UC 729-6一种人淋巴母细胞B细胞系可用于产生分泌抗体的人-人杂交瘤。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

UC 729-6, a 6-thioguanine-resistant human lymphoblastoid B-cell line, was fused with normal and malignant human lymphocytes. Parent UC 729-6 cells were diploid with a 21p+ marker chromosome, expressed surface and cytoplasmic IgM kappa, and doubled every 17 hr. The resulting human-human hybridomas were pseudotetraploid containing the 21p+ marker, doubled every 20-30 hr, and secreted 3-9 micrograms of human Ig per ml per 10(6) hybrid cells for greater than 9 months in continuous culture. Human Ig-secreting hybridomas were generated in 88% (14/16) of the fusions carried out and were cloned by limiting dilution (one cell per three wells) without the use of feeder layers. The mean fusion frequencies (number of wells, plated at 10(5) cells per well, showing hybrid growth per 10(6) lymphocytes fused) of UC 729-6 with normal lymphocytes ranged from 0.45 to 2.9 and with malignant B lymphocytes, from 3 to 10. Analysis of the human-human hybridomas derived from lymphocytes isolated from regional draining lymph nodes of cancer patients revealed several that secreted human monoclonal antibody that reacted by an enzyme immunoassay with some carcinoma cell lines but not with normal fibroblast cell lines. These data suggest that (i) UC 729-6 can be fused with human lymphocytes to generate stable human-human hybridomas, some of which secrete antibody reactive to human cell surface antigens, and (ii) UC 729-6 can be used to rescue Ig from nonsecretory malignant B cells and thereby allow for the production of anti-idiotype antibodies.
机译:UC 729-6是一种对六硫代鸟嘌呤有抗性的人淋巴母细胞B细胞系,与正常和恶性人淋巴细胞融合。亲本UC 729-6细胞是具有21p +标记染色体的二倍体,表达了表面和细胞质IgMκ,每17小时翻倍。所得的人-人杂交瘤是含有21p +标记的假四倍体,每20-30小时翻一番,并在连续培养中每10(6)个杂交细胞每毫升分泌3-9微克人Ig持续9个月以上。在进行的88%(14/16)融合中产生了分泌人Ig的杂交瘤,并通过有限稀释(每三个孔一个细胞)进行克隆,而无需使用饲养层。 UC 729-6与正常淋巴细胞的平均融合频率(孔数,每孔接种10(5)个细胞,显示出每融合10(6)个淋巴细胞的杂种生长)范围为0.45至2.9,恶性B淋巴细胞为图3至10。对从癌症患者的局部引流淋巴结分离的淋巴细胞衍生的人-人杂交瘤的分析显示,有几种分泌的人单克隆抗体通过酶免疫法与某些癌细胞系反应,但与正常的成纤维细胞系反应。这些数据表明(i)UC 729-6可与人淋巴细胞融合以生成稳定的人-人杂交瘤,其中一些分泌对人细胞表面抗原具有反应性的抗体,并且(ii)UC 729-6可用于抢救来自非分泌性恶性B细胞的Ig,从而可以产生抗独特型抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号